MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurological disorder characterised by pathological accumulation of amyloid-beta (Aβ) peptides and hyperphosphorylated tau protein in cortical tissue and neurodegeneration, resulting in progressive cognitive decline [1].